Onconova Therapeutics' Series H Round

Onconova Therapeutics raised a round of funding on July 26, 2012.

Onconova Therapeutics, a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule drug candidates to treat cancer. The company¬ís clinical-stage product candidate…

Articles about Onconova Therapeutics' Series H Round: